This test is most useful if any of these apply to you.
Most of the energy you use every day comes from burning fat inside tiny power stations in your cells (called mitochondria). When that main fat-burning route slows down or stalls, your body shifts to a backup pathway that leaves behind small, easy-to-measure leftovers in your urine. Suberic acid is one of those leftovers, and a higher-than-expected amount can be a clue that the main fat-burning machinery is not running smoothly.
This is a research-grade urine marker rather than an established yes-or-no test, so the value of measuring it comes from the pattern it forms with other organic acids and from how your own number changes over time. It is most useful as part of a broader urine organic acid panel, where it helps shape a picture of how your fat metabolism is actually behaving.
Suberic acid, also called octanedioic acid, is a dicarboxylic acid (a small organic acid with two acid groups on its ends). It is generated through a two-step process: longer-chain fatty acids are first partially processed by liver enzymes (a family called CYP4A) into longer dicarboxylic acids like sebacic acid and dodecanedioic acid, which are then shortened inside peroxisomes (small cellular compartments) to suberic acid. In other words, when fats cannot fully enter the normal energy-producing pathway, they get diverted into this side route, and suberic acid is one of the leftovers that ends up in your urine.
Because of this, the level of suberic acid in your urine is essentially a window onto how your body is handling fat. Low or background amounts suggest fats are entering the main energy pathway efficiently. Elevated amounts suggest that more fat than usual is being shunted into the backup route, either because the main pathway is overwhelmed, partially blocked, or genuinely impaired.
The clearest medical use of urinary suberic acid is in helping identify problems with how cells burn fat, known as fatty acid oxidation disorders. Studies of children with these conditions have repeatedly shown that suberic acid and other medium-chain dicarboxylic acids spill into the urine when the main fat-burning enzymes are not working properly.
In one of the most studied conditions, MCAD (medium-chain acyl-CoA dehydrogenase) deficiency, three patients showed a disproportionate rise in urinary medium-chain dicarboxylic acids, including suberic acid, with unsaturated dicarboxylic acids rising more sharply relative to controls than saturated ones did. A separate analysis of about 4,000 pediatric urine samples found that the ratio of adipic acid to 3-hydroxybutyrate above 0.5 served as a useful prognostic indicator for fatty acid oxidation disorders, and suberic acid moves alongside adipic acid in this pattern.
Suberic acid also rises in broader metabolic conditions that affect how cells handle fats. In a study of seven patients (six with neonatal adrenoleukodystrophy and one with Zellweger syndrome), both conditions showed excess medium- and long-chain dicarboxylic acids in urine, including suberic acid, making it part of a useful marker pattern for peroxisomal disorders. A separate case of riboflavin-responsive multiple acyl-CoA dehydrogenation defects showed the same C6 to C10 dicarboxylic aciduria signature.
Suberic acid has also shown up as a possible early warning of kidney damage from cisplatin, a common chemotherapy drug. In a metabolomics study of 31 adults with head and neck cancer, urinary suberate measured before cisplatin infusion was identified as a predictive and early biomarker of cisplatin-induced acute kidney injury, alongside glycine, hippuric acid sulfate, and 3-hydroxydecanedioic acid. A follow-up pediatric study from the same group did not replicate suberate as a key biomarker, so this finding is preliminary. It is a narrow, specific use rather than a general screening signal, but it suggests suberic acid can rise before standard kidney tests change.
There is preliminary research suggesting that urinary dicarboxylic acids change in early Alzheimer's disease. A study of pre-symptomatic adults found that urine dicarboxylic acid patterns (specifically C7 through C10 dicarboxylic acids) were higher in people with Alzheimer's disease and in cognitively healthy people with abnormal cerebrospinal fluid amyloid and tau levels, negatively correlated with hippocampal volume, and predicted cognitively healthy status with about 82% accuracy. This work treated dicarboxylic acids as a group rather than singling out suberic acid alone, so the link to suberic acid specifically is suggestive rather than confirmed.
One pregnancy cohort study of about 100 women found that plasma (not urinary) suberic acid was part of a fatty acid-enriched signature positively associated with preterm birth. The causality analysis inferred that suberic acid may upregulate several fatty acids in a way that promotes preterm birth. This finding comes from blood, not urine, so it is a useful clue about the biology but not direct evidence about what your urine number means for pregnancy outcomes.
Urinary suberic acid is highly responsive to what you eat, when you last ate, and how stressed your metabolism is at the moment of collection. A single reading captures a snapshot of fat handling in that moment, not a stable trait of your biology. Eating medium-chain triglyceride oil, going through a prolonged fast, or being acutely ill can all shift the number temporarily.
Because of this, the most useful approach is to get a baseline reading under your usual eating and activity pattern, and to repeat testing when something meaningful changes (such as a new dietary pattern, a supplement protocol, or a clinical concern that needs follow-up). Compare the trend, not the single value, and always interpret it alongside other organic acids in the same panel. There is no evidence-based schedule for routine retesting in adults; timing should be guided by a clinician based on what you are trying to learn.
A high reading does not automatically mean disease. Several common situations can temporarily push urinary suberic acid up without indicating an underlying problem with your fat-burning machinery.
Suberic acid is most useful when read alongside the rest of the urine organic acid profile. An isolated mild elevation is usually not actionable on its own. A pattern that combines elevated suberic acid with elevated adipic acid, sebacic acid, or specific 3-hydroxy dicarboxylic acids is more meaningful, because that pattern points toward a specific stage of fat metabolism where things may be slowing down.
If your suberic acid is elevated and the pattern looks unusual, the next steps are typically: retest under controlled conditions (consistent diet, no recent fasting, no MCT supplementation, well-rested); order a complete organic acid panel if you only ran a subset; and consider companion testing including an acylcarnitine profile, which captures fat-metabolism intermediates earlier in the pathway. If a metabolic specialist is involved, they may also recommend specific genetic testing for fatty acid oxidation enzymes when the urine and acylcarnitine pattern raises that suspicion.
What this is not: a stand-alone diagnostic test for any single disease. Standardized clinical cutpoints for adults do not exist, and a single mildly elevated value should never drive a treatment decision in isolation. Urinary organic acid testing is primarily established in pediatric metabolic medicine for diagnosing inherited disorders rather than for longitudinal adult metabolic monitoring.
Evidence-backed interventions that affect your Suberic Acid level
Suberic Acid is best interpreted alongside these tests.
Suberic Acid is included in these pre-built panels.